Cover Image

Not for Sale



View/Hide Left Panel

Patients with Malignancies (Leukemias)

Category C

 

 

# of cases=1,036

 

 

100% of cases typically receive 18 additional days ICU at $600/day

= $

11,189,000

100% of cases typically receive additional diagnostic testing and treatment procedures at rate equivalent to daily inclusive hospital rate 18 days at $600/day

= $

11,189,000

 

TOTAL COST

= $

22,378,000

 

TOTAL COST FOR CMV

= $

1,000,544,000

Cost of Vaccine Preventable Illness

Glycoprotein Vaccine for Normal Children

 

 

100% of congenital and perinatal infection

= $

435,608,000

100% of mononucleosis and other febrile illnesses

= $

54,261,000

100% of post-transfusion disease in people over 1 year, but 0% in infants under 1 year (25,713 in Category C only)

= $

334,269,000

 

TOTAL COST

= $

824,138,000

Live Attenuated Vaccine for High-Risk individuals

 

 

50% of all disease burden in IC patients (transplant recipients, patients with malignancies)

= $

29,826,000

 

TOTAL COST

= $

29,826,000

Live Attenuated Vaccine for Nonpregnant Adolescent Females

 

 

90% of congenital and perinatal infection

= $

392,047,000

 

TOTAL COST

= $

392,047,000

References

Adler, S.P., T.Chandrika, L.Lawrence, and J.Baggett. 1983. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr. Infect. Dis. 2(2):114–118.

Albrecht, T., and F.Rapp. 1973. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 55:53–61.

Alford, C. 1983. Personal communication. University of Alabama, Birmingham.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement